← Back to headlines
Canaccord Increases Wave Life Sciences Price Target After Pipeline Review
Canaccord has raised its price target for Wave Life Sciences Ltd. (WVE) to $52 following a comprehensive review of the company's pipeline.
30 Mar, 11:40 — 30 Mar, 11:40
Sources
Showing 1 of 1 sources
